Location: Bend, OR
CIK: 0001440771 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 13, 2024
Total Value: $231M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EOLS | EVOLUS INC | 5,333,004 | $56.16M | 24.3% | $8.66 | +3.3% | COM | 30052C107 |
| ADMA | ADMA BIOLOGICS INC | 9,222,617 | $41.69M | 18.0% | $2.26 | +63.4% | COM | 000899104 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 2,500,000 | $36.8M | 15.9% | $23.76 | -35.5% | COM | 03237H101 |
| QDEL | QUIDELORTHO CORP | 450,000 | $33.16M | 14.3% | $89.16 | -24.2% | COM | 219798105 |
| — | ALIMERA SCIENCES INC | 3,999,459 | $17.28M | 7.5% | $3.10 | — | COM NEW | 016259202 |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 5,937,000 | $13.95M | 6.0% | $2.16 | -14.4% | COM | 98422E103 |
| GLPG | GALAPAGOS NV-SPON ADR | 261,870 | $10.65M | 4.6% | $39.25 | — | SPONS ADR | 36315X101 |
| XOMA | XOMA CORP | 250,000 | $4.625M | 2.0% | $19.70 | -16.4% | COM NEW | 98419J206 |
| IOBT | IO BIOTECH INC | 1,666,037 | $3.132M | 1.4% | $1.76 | -32.2% | COM | 449778109 |
| SCYX | SCYNEXIS INC | 1,355,186 | $3.022M | 1.3% | $2.73 | -32.8% | COM NEW | 811292200 |
| RZLT | REZOLUTE INC | 2,768,656 | $2.748M | 1.2% | $3.88 | -76.4% | COM NEW | 76200L309 |
| AVIR | ATEA PHARMACEUTICALS INC | 839,514 | $2.561M | 1.1% | $3.68 | -17.6% | COM | 04683R106 |
| TELA | TELA BIO INC | 317,782 | $2.104M | 0.9% | $10.21 | -43.4% | COM | 872381108 |
| AYTU | AYTU BIOPHARMA INC | 472,469 | $1.342M | 0.6% | $1.96 | +40.3% | COM | 054754858 |
| XGN | EXAGEN INC | 669,684 | $1.333M | 0.6% | $8.92 | -80.6% | COM | 30068X103 |
| ATYR | ATYR PHARMA INC | 482,258 | $680K | 0.3% | $2.19 | -41.5% | COM NEW | 002120202 |